HCW Biologics is trading 11.27% up at $2.36 now, with no clear company-specific catalyst identified for August 21, 2026.
- Its latest official release was the August 14, 2026 second-quarter results and clinical-development update; no newer release was listed for August 21.
- Broader U.S. markets were modestly higher pre-market, but the rebound appears unexplained and may reflect speculative trading.